HIV/AIDS Topics Many More Could Benefit from HIV PrEP, But Not Enough Doctors Are Aware
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Monday, 30 November 2015 00:00
- Written by Liz Highleyman
One-quarter of gay and bisexual men in the U.S. and one-fifth of people who inject drugs, but less than 1% of heterosexual men and women, could benefit from Truvada pre-exposure prophylaxis or PrEP -- more than 1.2 million people in total -- according to a new Centers for Disease Control and Prevention (CDC) Vital Signs report released ahead of World AIDS Day. But a nationwide survey found that one-third of U.S. healthcare providers had not heard about PrEP, prompting the CDC to launch an expanded awareness effort.
France Approves Truvada for HIV Pre-exposure Prophylaxis
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Tuesday, 24 November 2015 00:00
- Written by Gus Cairns
In a historic move, France has become the first country outside the U.S., and the first country with a centrally organized, reimbursable health system, to approve no-expense pre-exposure prophylaxis (PrEP) for people who need it. The French Minister of Health, Marisol Touraine, announced on November 24 today that PrEP would be available starting in mid-December, and reimbursable through the French health system from the beginning of January.
How Do We Maximize HIV Treatment Access? IAPAC Care Continuum Guidelines Make Recommendations
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Tuesday, 17 November 2015 00:00
- Written by Gus Cairns
IAPAC, the International Association of Practitioners in AIDS Care, has issued a set of guidelines that aims to establish a common set of best practices to ensure that as many people living with HIV as possible are diagnosed, cared for, receive treatment, and achieve undetectable viral loads.
EACS 2015: Barcelona Clinic Study Counts How Many Gay Men Might Benefit from PrEP
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Thursday, 19 November 2015 00:00
- Written by Gus Cairns
A study from the Barcelona Checkpoint gay men’s HIV clinic, presented at the recent 15th European AIDS Conference, has found a strong and consistent relationship between the annual HIV infection rate (incidence) of different categories of clinic users and the particular combination of risk factors they self-report. The primary intention behind this study was to estimate what proportion of clinic users might benefit from HIV pre-exposure prophylaxis (PrEP). In doing the exercise, however, the clinic also managed to establish interesting new estimates for the relative contribution to HIV risk of condomless sex, sexually transmitted infections, high sex partner numbers, and sexual role.
Truvada PrEP Appears to Work for Transgender Women, But Only If Used Consistently
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Sunday, 08 November 2015 00:00
- Written by Liz Highleyman
The more than 300 transgender women in the pivotal iPrEx pre-exposure prophylaxis (PrEP) trial had similar overall HIV infection rates whether they were randomized to take Truvada or placebo, but those with drug levels indicating consistent PrEP use appeared to be protected, researchers reported in the November 5 advance online edition of The Lancet.
Web Design and Development by